Davis Jerel
CIK 1745958 · last filed 2025-08-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
KDNY price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SAN FRANCISCO, CA 94104
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Turnstone Biologics Corp. (TSBX) Delisted | Director | 0 | $0.35 | $0 | $2.70M | 4 | 2025-08-08 |
| CHINOOK THERAPEUTICS, INC. (KDNY) Delisted | Director | 0 | $40.39 | $0 | -$43.14M | 14 | 2023-08-11 |
| LENZ Therapeutics, Inc. (GRPH) Delisted | Director | 243,960 | $22.26 | $5.43M | $3.06M | 4 | 2023-07-21 |
| Repare Therapeutics Inc. (RPTX) Delisted | Director | 22,117 | $2.65 | $58.6K | -$8.19M | 13 | 2023-01-03 |
Recent Filings · Page 2 of 4
35 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-12-27 | CHINOOK THERAPEUTICS, INC. (KDNY) Delisted | Other (J) | −471,656 | $0 | EDGAR |
| 2022-12-13 | Repare Therapeutics Inc. (RPTX) Delisted | Sell (S) | −250,000 | -$4.00M | EDGAR |
| 2022-09-14 | CHINOOK THERAPEUTICS, INC. (KDNY) Delisted | Other (J) | −943,314 | $0 | EDGAR |
| 2022-08-16 | CHINOOK THERAPEUTICS, INC. (KDNY) Delisted | Other (J) | −471,656 | $0 | EDGAR |
| 2022-06-22 | LENZ Therapeutics, Inc. (GRPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-07 | Repare Therapeutics Inc. (RPTX) Delisted | Mixed | −1,440,899 | -$9.19M | EDGAR |
| 2022-05-31 | CHINOOK THERAPEUTICS, INC. (KDNY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-16 | Repare Therapeutics Inc. (RPTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-04-06 | CHINOOK THERAPEUTICS, INC. (KDNY) Delisted | Other (J) | −707,485 | $0 | EDGAR |
| 2022-03-03 | CHINOOK THERAPEUTICS, INC. (KDNY) Delisted | — | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.